IL231381A0 - Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL231381A0
IL231381A0 IL231381A IL23138114A IL231381A0 IL 231381 A0 IL231381 A0 IL 231381A0 IL 231381 A IL231381 A IL 231381A IL 23138114 A IL23138114 A IL 23138114A IL 231381 A0 IL231381 A0 IL 231381A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
aminopyrimidine derivatives
aminopyrimidine
Prior art date
Application number
IL231381A
Other languages
Hebrew (he)
Other versions
IL231381B (en
Original Assignee
Merck Patent Gmbh
Chen Xiaoling
Xiao Yufang
Huck Bayard R
Neagu Constantin
Lgor Mochalkin
Deselm Lizbeth Celeste
Lan Rouxi
Qiu Hui
Johnson Theresa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Chen Xiaoling, Xiao Yufang, Huck Bayard R, Neagu Constantin, Lgor Mochalkin, Deselm Lizbeth Celeste, Lan Rouxi, Qiu Hui, Johnson Theresa filed Critical Merck Patent Gmbh
Publication of IL231381A0 publication Critical patent/IL231381A0/en
Publication of IL231381B publication Critical patent/IL231381B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL231381A 2011-09-12 2014-03-06 Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them IL231381B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161533606P 2011-09-12 2011-09-12
PCT/US2012/054877 WO2013040044A1 (en) 2011-09-12 2012-09-12 Aminopyrimidine derivatives for use as modulators of kinase activity

Publications (2)

Publication Number Publication Date
IL231381A0 true IL231381A0 (en) 2014-04-30
IL231381B IL231381B (en) 2019-05-30

Family

ID=46964039

Family Applications (2)

Application Number Title Priority Date Filing Date
IL231381A IL231381B (en) 2011-09-12 2014-03-06 Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them
IL266510A IL266510B (en) 2011-09-12 2019-05-07 Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL266510A IL266510B (en) 2011-09-12 2019-05-07 Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (3) US9321760B2 (en)
EP (1) EP2755958B9 (en)
JP (1) JP6082011B2 (en)
KR (1) KR101992505B1 (en)
CN (2) CN106946796B (en)
AU (2) AU2012308681B2 (en)
BR (1) BR112014005468A2 (en)
CA (1) CA2844704C (en)
DK (1) DK2755958T3 (en)
EA (1) EA028057B1 (en)
ES (1) ES2646759T3 (en)
HK (1) HK1198168A1 (en)
HR (1) HRP20171655T1 (en)
HU (1) HUE034979T2 (en)
IL (2) IL231381B (en)
LT (1) LT2755958T (en)
MX (1) MX347241B (en)
NO (1) NO2639780T3 (en)
PL (1) PL2755958T3 (en)
PT (1) PT2755958T (en)
RS (1) RS56486B1 (en)
SG (1) SG2014009260A (en)
SI (1) SI2755958T1 (en)
WO (1) WO2013040044A1 (en)
ZA (1) ZA201401007B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013030442B1 (en) 2011-06-10 2021-11-09 Merck Patent Gmbh PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY, THEIR USES, COMPOSITION, AND KIT
EP2755958B9 (en) * 2011-09-12 2018-02-28 Merck Patent GmbH Aminopyrimidine derivatives for use as modulators of kinase activity
EP2920178B1 (en) 2012-11-16 2016-12-21 Merck Patent GmbH Novel heterocyclic derivatives as modulators of kinase activity (p70s6 and akt)
ES2746756T3 (en) 2013-03-11 2020-03-06 Merck Patent Gmbh Derivatives of 6- [4- (1H-imidazol-2-yl) piperidin-1-yl] pyrimidin-4-amine as modulators of kinase activity
EP3094627B1 (en) 2014-01-17 2018-08-22 Novartis AG 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
JO3517B1 (en) 2014-01-17 2020-07-05 Novartis Ag N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
ES2699354T3 (en) 2014-01-17 2019-02-08 Novartis Ag Derivatives of 1- (triazin-3-yl / pyridazin-3-yl) -piper (-azin) idine and compositions thereof to inhibit the activity of SHP2
JP6560243B2 (en) * 2014-02-11 2019-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Pyrimidineimidazolamine as a modulator of kinase activity
EP2939514B1 (en) 2014-04-30 2018-09-05 LG Electronics Inc. Lawn mower robot and control method thereof
KR102518994B1 (en) * 2014-05-28 2023-04-05 아스트라제네카 아베 Processes for the preparation of azd5363 and novel intermediate used therein
ES2741746T3 (en) 2015-06-19 2020-02-12 Novartis Ag Compounds and compositions to inhibit SHP2 activity
JP6878316B2 (en) 2015-06-19 2021-05-26 ノバルティス アーゲー Compounds and compositions for inhibiting the activity of SHP2
WO2016203406A1 (en) 2015-06-19 2016-12-22 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
WO2017019804A2 (en) 2015-07-28 2017-02-02 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
JP6921846B6 (en) * 2016-03-16 2021-09-15 プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． Compounds and methods for kinase regulation and its indications
BR112018075663A2 (en) 2016-06-14 2019-04-09 Novartis Ag compounds and compositions for inhibiting shp2 activity
CN109467538A (en) * 2017-09-07 2019-03-15 和记黄埔医药（上海）有限公司 The heteroaryl cyclics and application thereof that cycloolefin replaces
WO2019084395A1 (en) 2017-10-27 2019-05-02 University Of Virginia Patent Foundation Compounds and methods for regulating, limiting, or inhibiting avil expression
EP3962485A4 (en) * 2019-05-02 2022-12-28 University Of Virginia Patent Foundation Substituted (piperidin-1-yl)aryl analogues for modulating avilactivity
US11866421B2 (en) 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137755A1 (en) * 2000-12-04 2002-09-26 Bilodeau Mark T. Tyrosine kinase inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
WO2004092154A1 (en) 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
WO2005033086A1 (en) 2003-09-30 2005-04-14 Irm Llc Compounds and compositions as protein kinase inhibitors
JP4800216B2 (en) 2003-10-24 2011-10-26 エグゼリクシス， インコーポレイテッド p70S6 kinase modulator and methods of use
EP1687305B1 (en) 2003-11-21 2008-07-09 Novartis AG 1h-imidazoquinoline derivatives as protein kinase inhibitors
KR20110137838A (en) * 2003-11-21 2011-12-23 어레이 바이오파마 인크. Akt protein kinase inhibitors
EP1694331B8 (en) 2003-12-09 2010-02-24 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods for suppressing an immune response or treating a proliferating disorder
US8076338B2 (en) 2004-04-23 2011-12-13 Exelixis, Inc. Kinase modulators and methods of use
CA2590961C (en) * 2004-12-28 2013-11-26 Exelixis, Inc. [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
AU2006206246A1 (en) 2005-01-19 2006-07-27 Neurogen Corporation Heteroaryl substituted piperazinyl-pyridine analogues
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
EP1902032A1 (en) 2005-06-22 2008-03-26 Astex Therapeutics Limited Pharmaceutical compounds
WO2007125321A2 (en) * 2006-04-25 2007-11-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
WO2008012635A2 (en) * 2006-07-26 2008-01-31 Pfizer Products Inc. Amine derivatives useful as anticancer agents
WO2008061108A2 (en) * 2006-11-15 2008-05-22 Forest Laboratories Holdings Limited Phthalazine derivatives
JP2010513458A (en) * 2006-12-19 2010-04-30 ファイザー・プロダクツ・インク Nicotinamide derivatives as inhibitors of H-PGDS and their use to treat prostaglandin D2-mediated diseases
UA99284C2 (en) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані P70 s6 kinase inhibitors
AR074072A1 (en) 2008-11-11 2010-12-22 Lilly Co Eli COMPOSITE OF IMIDAZOL -PIPERIDIN -PIRROL-PIRIMIDIN-6-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT TO TREAT MULTIFORM GLIOBLASTOMA
NZ595087A (en) 2009-02-11 2013-03-28 Merck Patent Gmbh Novel amino azaheterocyclic carboxamides
US9029359B2 (en) * 2009-09-04 2015-05-12 Biogen Idec Ma, Inc. Heteroaryl Btk inhibitors
UA110113C2 (en) 2010-07-29 2015-11-25 BICYCLIC AZAGETEROCYCLIC CARBOXAMIDES
CN103140484B (en) 2010-07-29 2015-04-22 默克专利有限公司 Cyclic amine azaheterocyclic carboxamides
PT2643313T (en) 2010-11-24 2016-10-11 Merck Patent Gmbh Quinazoline carboxamide azetidines
RS56534B1 (en) * 2011-09-12 2018-02-28 Merck Patent Gmbh Novel imidazole amines as modulators of kinase activity
EP2755958B9 (en) * 2011-09-12 2018-02-28 Merck Patent GmbH Aminopyrimidine derivatives for use as modulators of kinase activity
CA2890345A1 (en) * 2012-11-16 2014-05-22 Merck Patent Gmbh Imidazol-piperidinyl derivatives as modulators of kinase activity
JP6560243B2 (en) * 2014-02-11 2019-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Pyrimidineimidazolamine as a modulator of kinase activity

Also Published As

Publication number Publication date
US9662330B2 (en) 2017-05-30
US9321760B2 (en) 2016-04-26
AU2017245469A1 (en) 2017-11-02
DK2755958T3 (en) 2017-09-25
LT2755958T (en) 2017-11-10
CA2844704C (en) 2020-04-28
US20160184308A1 (en) 2016-06-30
IL266510B (en) 2021-01-31
PL2755958T3 (en) 2017-12-29
HRP20171655T1 (en) 2017-12-15
IL231381B (en) 2019-05-30
MX347241B (en) 2017-04-20
EP2755958A1 (en) 2014-07-23
PT2755958T (en) 2017-11-14
AU2017245469B2 (en) 2019-05-23
SG2014009260A (en) 2014-09-26
ZA201401007B (en) 2018-07-25
KR101992505B1 (en) 2019-06-24
CN103930407A (en) 2014-07-16
HUE034979T2 (en) 2018-05-02
EA028057B1 (en) 2017-10-31
HK1198168A1 (en) 2015-03-13
EP2755958B9 (en) 2018-02-28
MX2014002836A (en) 2014-05-28
US20150126484A1 (en) 2015-05-07
BR112014005468A2 (en) 2017-03-21
ES2646759T3 (en) 2017-12-15
WO2013040044A1 (en) 2013-03-21
CN103930407B (en) 2019-02-26
RS56486B1 (en) 2018-01-31
JP2014527082A (en) 2014-10-09
KR20140062494A (en) 2014-05-23
CN106946796B (en) 2020-05-08
SI2755958T1 (en) 2017-12-29
IL266510A (en) 2019-07-31
EP2755958B1 (en) 2017-08-09
CN106946796A (en) 2017-07-14
US10080750B2 (en) 2018-09-25
AU2012308681A1 (en) 2014-02-27
NO2639780T3 (en) 2018-06-23
EA201400338A1 (en) 2014-12-30
US20170217905A1 (en) 2017-08-03
JP6082011B2 (en) 2017-02-15
CA2844704A1 (en) 2013-03-21
AU2012308681B2 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
IL266510B (en) Aminopyrimidine derivatives, their preparation and pharmaceutical compositions containing them
IL229863A (en) Pyrimidine and pyridine derivatives, their preparation and pharmaceutical compositions containing them
IL236542B (en) Pyrimidine pyrazolyl derivatives, their preparation and pharmaceutical compositions containing them
IL237839A0 (en) Hydropyrrolopyrrole derivatives, their preparation and pharmaceutical compositions containing them
IL237073A (en) Pyridopyrimidine derivatives, their preparation and pharmaceutical compositions containing them
EP2746283A4 (en) Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof
IL231008A (en) Thiazole derivatives, their preparation and pharmaceutical compositions containing them
IL230218A (en) Substituted azaheterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL235414A (en) Pyrrolotriazinone derivatives, their preparation and pharmaceutical compositions containing them
IL225626A0 (en) Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them
IL237072B (en) Isoquinolinone derivatives, their preparation and pharmaceutical compositions containing them
IL225824A0 (en) Quinoxaline derivatives, their preparation and pharmaceutical compositions containing them
EP2702054A4 (en) Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
IL232217A (en) Azole derivatives, pharmaceutical compositions comprising them and their uses
PL2562172T3 (en) Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses
IL232577A (en) Morpholinylbenzotriazine derivatives, their preparation and pharmaceutical compositions containing them
IL238825B (en) Heterocyclic derivatives, their preparation and phermaceutical compositions containing them
IL226094A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL231383A (en) Imdiazole amine derivatives, their preparation and pharmaceutical compositions containing them
IL238060B (en) 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them
IL227404A0 (en) Pyrimidine derivatives, their preparation and pharmaceutical composition containing them
IL233602A (en) Benzamide derivatives, their preparation and pharmaceutical compositions containing them
IL239054B (en) Azaquinazoline carboxamide derivatives, their preparation and pharmaceutical compositions containing them
EP2742020A4 (en) N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
IL235955A0 (en) Benzothiophen derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed